Remimazolam NeuroImaging
Neuroimaging of Sedation With Remimazolam
Keith M Vogt
60 participants
Mar 27, 2026
INTERVENTIONAL
Conditions
Summary
This is a single-arm functional MRI study that will determine the effects of remimazolam on cognition and brain activity and connectivity at rest, during noxious stimulation, and during a memory encoding task
Eligibility
Inclusion Criteria1
- Adults 18-59 years of age, who:
Exclusion Criteria20
- have a valid email address and valid phone number throughout the study
- free from any non-MRI compatible implants
- are pregnant or attempting to conceive
- body mass index (BMI) \> 35
- significant memory impairment or hearing loss
- sleep apnea
- chronic pain or frequently taking pain medication (including tramadol)
- chronic medical conditions requiring treatment (hypertension, diabetes, high cholesterol)
- neurologic disease, including seizures and tremor
- psychiatric diagnoses, including anxiety, depression, panic, or PTSD
- a history of any of these medical conditions: abnormal heartbeats (cardiac conduction abnormality or arrhythmia), liver or kidney disease, or significant lung disease
- severe claustrophobia or MRI intolerance
- have metal implants or non-removable metal piercings
- having a history of adverse reaction to midazolam (Versed), lorazepam (Ativan) or another benzodiazepine class medication
- are allergic to dextran
- daily alcohol or heavy alcohol use; history of alcohol abuse
- current daily smoker
- regular or recent marijuana use (including prescribed/medical marijuana)
- illicit drug use, i.e., street drugs
- regularly taking: antiepileptics, antidepressants, anti-psychotics, antihistamines, anti-anxiety medication, stimulants, or sleep-aids
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Subjects in this group will receive an intravenous infusion of this drug, during a portion of the study.
Experimental acute pain stimulus will be delivered using a nerve stimulator. These painful shocks will be paired with a fixed number of the experimental cues, in a pattern that appears random to participants.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07290205